XML 41 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share-Based Compensation (Tables)
6 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding

A summary of the stock option activity under the Company’s plans for the six months ended December 31, 2015 is as follows:

 

     Number
of
shares
     Weighted
average
exercise
price
 

Options outstanding at June 30, 2015

     12.5       $ 23.49   

Options granted

     —         $ —     

Less:

     

Options exercised

     (4.0    $ 21.38   

Options canceled or expired

     —         $ —     
  

 

 

    

Options outstanding at December 31, 2015

     8.5       $ 24.50   
  

 

 

    

Options exercisable at December 31, 2015

     6.9       $ 24.00   
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Restricted Stock Units Outstanding

A summary of the RSU activity under the Company’s plans for the six months ended December 31, 2015 is as follows:

 

     Number
of
shares
     Weighted
average
grant date
fair value
 

RSUs outstanding at June 30, 2015

     1.0       $ 37.63   

RSUs granted

     0.8       $ 40.66   

Less:

     

RSUs vested

     (0.3    $ 39.74   

RSUs canceled

     —         $ —     
  

 

 

    

RSUs outstanding at December 31, 2015

     1.5       $ 38.80   
  

 

 

    
Schedule of Share-Based Compensation Recognized in Consolidated Statements of Operations

Share-based compensation expense recognized and included in the condensed consolidated statements of income and comprehensive income was allocated as follows:

 

     Three months ended
December 31,
     Six months ended
December 31,
 
     2015      2014      2015      2014  

Cost of molecular diagnostic testing

   $ 0.3       $ 0.2       $ 0.5       $ 0.4   

Cost of pharmaceutical and clinical services

     0.1         0.1         0.2         0.3   

Research and development expense

     1.2         1.3         2.8         2.0   

Selling, general, and administrative expense

     6.1         10.5         12.8         16.3   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total share-based compensation expense

   $ 7.7       $ 12.1       $ 16.3       $ 19.0